Viatris (FRA:VIA) Ending Cash Position : €935 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Viatris Ending Cash Position?

Viatris's Ending Cash Position for the quarter that ended in Mar. 2024 was €935 Mil.

Viatris's quarterly Ending Cash Position declined from Sep. 2023 (€1,229 Mil) to Dec. 2023 (€911 Mil) but then increased from Dec. 2023 (€911 Mil) to Mar. 2024 (€935 Mil).

Viatris's annual Ending Cash Position increased from Dec. 2021 (€625 Mil) to Dec. 2022 (€1,192 Mil) but then declined from Dec. 2022 (€1,192 Mil) to Dec. 2023 (€911 Mil).

Viatris Ending Cash Position Historical Data

The historical data trend for Viatris's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viatris Ending Cash Position Chart

Viatris Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

441.99

698.70

624.99

1,191.80

911.13

Viatris Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															476.99	582.78	1,229.16	911.13	934.63

Viatris Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Viatris's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1157.712	+	-246.581
	=	911

Viatris's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	914.112	+	20.516
	=	935

Viatris Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Viatris's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Viatris (FRA:VIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viatris Inc (FRA:VIA) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

VTRS:USA MYL:Mexico 1VTRS:Italy 0A5V:UK VIA:Germany MYL:Austria

Address

1000 Mylan Boulevard, Canonsburg, PA, USA, 15317

Website

https://www.viatris.com

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.